SARS-CoV-2 Antigen Rapid Test
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.
High Quality
• High sensitivity and specificity
• High reproducibility
• Consistent and reliable performance
Easy to Use
• Standardized, color-coded and numbered reagents
• Ready-to-use reagents shorten initial prep time
• Room temperature incubation
• Total incubation time: 75 min
Convenient
• All necessary reagents provided
• Breakaway 8-well strips / 96-microwell plate in re-sealable foil pouch
• Shelf life of 12 months
|
Feature |
SARS-CoV-2 IgG |
SARS-CoV-2 IgM |
|
Detection |
IgG antibodies to SARS-CoV-2 |
IgM antibodies to SARS-CoV-2 |
|
Type of Test |
Qualitative |
Qualitative |
|
Principle |
Indirect EIA |
Capture EIA |
|
Specimen Type |
Serum/Plasma |
Serum/Plasma |
|
Specimen Volume |
5 μL |
5 μL |
|
Specimen Diluent Volume |
100 μL |
100 μL |
|
Neutralization Solution Volume |
N/A |
N/A |
|
Conjugate Volume |
100 μL |
100 μL |
|
Substrate A/B Volume |
50 μL/50 μL |
50 μL/50 μL |
|
Stop Solution Volume |
50 μL |
50 μL |
|
Total Incubation Time |
70 minute (30/30/10) |
70 minute (30/30/10) |
|
Wavelength |
450/630-700 nm |
450/630-700 nm |
|
Sensitivity |
>99.9%(95%CI: 92.1%~100%) |
88.6%(95%CI: 76.0%~95.0%) |
|
Specificity |
99.4%(95%CI: 96.9%~100%) |
97.8%(95%CI: 94.6%~99.2%) |
|
Overall Agreement |
99.6%(95%CI: 97.5%~100%) |
96.1%(95%CI: 92.7%~97.9%) |
|
Within-Run Precision CV(%) |
<9% |
<12% |
|
Between-Run Precision CV(%) |
<15% |
<13% |
|
Shelf Life |
12 months |
12 months |
|
Product Name |
Catalog No. |
Test per Kit |
|
SARS-CoV-2 IgG |
I231-1321 |
96/480 |
|
SARS-CoV-2 IgM |
I231-1331 |
96/480 |
